-
1
-
-
0026320943
-
The kit receptor and its ligand, steel factor, as regulators of hemopoiesis
-
Broxmeyer, H. E. et al. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 3, 480-487 (1991).
-
(1991)
Cancer Cells
, vol.3
, pp. 480-487
-
-
Broxmeyer, H.E.1
-
2
-
-
0025756650
-
Growth factors and tyrosine protein kinases in normal andmalignant melanocytes
-
Halaban, R. Growth factors and tyrosine protein kinases in normal andmalignant melanocytes. Cancer Metastasis Rev. 10, 129-140 (1991).
-
(1991)
Cancer Metastasis Rev
, vol.10
, pp. 129-140
-
-
Halaban, R.1
-
3
-
-
0028796630
-
W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
-
Huizinga, J. D. et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373, 347-349 (1995).
-
(1995)
Nature
, vol.373
, pp. 347-349
-
-
Huizinga, J.D.1
-
4
-
-
0026039464
-
Activation of the human c-kit product by ligand-induced dimerizationmediates circular actin reorganization and chemotaxis
-
Blume-Jensen, P. et al. Activation of the human c-kit product by ligand-induced dimerizationmediates circular actin reorganization and chemotaxis. EMBO J. 10, 4121-4128 (1991).
-
(1991)
EMBO J
, vol.10
, pp. 4121-4128
-
-
Blume-Jensen, P.1
-
5
-
-
0027496310
-
Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or FcRI: Rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells
-
Tsai, M., Chen, R., Tam, S., Blenis, J. & Galli, S. J. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or FcRI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur. J. Immunol. 23, 3286-3291 (1993).
-
(1993)
Eur. J. Immunol
, vol.23
, pp. 3286-3291
-
-
Tsai, M.1
Chen, R.2
Tam, S.3
Blenis, J.4
Galli, S.J.5
-
6
-
-
0033558357
-
Mitogen-activated protein kinase activation through Fc epsilon receptor i and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells
-
Ishizuka, T. et al. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol. 162, 2087-2094 (1999).
-
(1999)
J. Immunol
, vol.162
, pp. 2087-2094
-
-
Ishizuka, T.1
-
7
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
Hirota, S. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580 (1998).
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
-
8
-
-
33750609891
-
Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin
-
Corbacioglu, S. et al. Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin. Blood 108, 3504-3513 (2006).
-
(2006)
Blood
, vol.108
, pp. 3504-3513
-
-
Corbacioglu, S.1
-
9
-
-
33749021085
-
Somatic activation of KIT in distinct subtypes of melanoma
-
Curtin, J. A., Busam, K., Pinkel, D. & Bastian, B. C. Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340-4346 (2006).
-
(2006)
J. Clin. Oncol
, vol.24
, pp. 4340-4346
-
-
Curtin, J.A.1
Busam, K.2
Pinkel, D.3
Bastian, B.C.4
-
10
-
-
34250024319
-
Recent advances in the understanding of mastocytosis: The role of KIT mutations
-
Orfao, A., Garcia-Montero, A. C., Sanchez, L. & Escribano, L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br. J. Haematol. 138, 12-30 (2007).
-
(2007)
Br. J. Haematol
, vol.138
, pp. 12-30
-
-
Orfao, A.1
Garcia-Montero, A.C.2
Sanchez, L.3
Escribano, L.4
-
11
-
-
0029962928
-
A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells
-
Piao, X. & Bernstein, A. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 87, 3117-3123 (1996).
-
(1996)
Blood
, vol.87
, pp. 3117-3123
-
-
Piao, X.1
Bernstein, A.2
-
12
-
-
0028959163
-
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines
-
Kitayama, H. et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85, 790-798 (1995).
-
(1995)
Blood
, vol.85
, pp. 790-798
-
-
Kitayama, H.1
-
13
-
-
9044251604
-
Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3- dependent mast cell line
-
Hashimoto, K. et al. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3- dependent mast cell line. Am. J. Pathol. 148, 189-200 (1996).
-
(1996)
Am. J. Pathol
, vol.148
, pp. 189-200
-
-
Hashimoto, K.1
-
14
-
-
0022637589
-
Expression of interleukin 2 receptors on interleukin 3-dependent cell lines
-
Koyasu, S. et al. Expression of interleukin 2 receptors on interleukin 3-dependent cell lines. J. Immunol. 136, 984-987 (1986).
-
(1986)
J. Immunol
, vol.136
, pp. 984-987
-
-
Koyasu, S.1
-
15
-
-
0024469094
-
Growth regulation of multi-factor-dependent myeloid cell lines: IL-4, TGF-beta and pertussis toxin modulate IL-3- or GM-CSF-induced growth by controlling cell cycle length
-
Koyasu, S. et al. Growth regulation of multi-factor-dependent myeloid cell lines: IL-4, TGF-beta and pertussis toxin modulate IL-3- or GM-CSF-induced growth by controlling cell cycle length. Cell Struct. Funct. 14, 459-471 (1989).
-
(1989)
Cell Struct. Funct
, vol.14
, pp. 459-471
-
-
Koyasu, S.1
-
16
-
-
0032989226
-
C-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia
-
Gari, M. et al. c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. Br. J. Haematol. 105, 894-900 (1999).
-
(1999)
Br. J. Haematol
, vol.105
, pp. 894-900
-
-
Gari, M.1
-
17
-
-
17044435979
-
KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor
-
Kohl, T. M., Schnittger, S., Ellwart, J. W., Hiddemann, W. & Spiekermann, K. KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor. Blood 105, 3319-3321 (2005).
-
(2005)
Blood
, vol.105
, pp. 3319-3321
-
-
Kohl, T.M.1
Schnittger, S.2
Ellwart, J.W.3
Hiddemann, W.4
Spiekermann, K.5
-
18
-
-
0033883060
-
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
-
Lux, M. L. et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am. J. Pathol. 156, 791-795 (2000).
-
(2000)
Am. J. Pathol
, vol.156
, pp. 791-795
-
-
Lux, M.L.1
-
19
-
-
2542520755
-
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)
-
Duensing, A. et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 23, 3999-4006 (2004).
-
(2004)
Oncogene
, vol.23
, pp. 3999-4006
-
-
Duensing, A.1
-
20
-
-
84879957303
-
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (D419del)
-
Huss, S. et al. A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (D419del). Mod. Pathol. 26, 1004-1012 (2013).
-
(2013)
Mod. Pathol
, vol.26
, pp. 1004-1012
-
-
Huss, S.1
-
21
-
-
76649094569
-
Pediatricmastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations
-
Bodemer, C. et al. Pediatricmastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J. Invest. Dermatol. 130, 804-815 (2009).
-
(2009)
J. Invest. Dermatol
, vol.130
, pp. 804-815
-
-
Bodemer, C.1
-
22
-
-
0037421971
-
A human brain tumor-derived PDGFR-A deletion mutant is transforming
-
Clarke, I. & Dirks, P. A human brain tumor-derived PDGFR-a deletion mutant is transforming. Oncogene 22, 722-733 (2003).
-
(2003)
Oncogene
, vol.22
, pp. 722-733
-
-
Clarke, I.1
Dirks, P.2
-
23
-
-
0025190309
-
FMSmutations in myelodysplastic, leukemic, and normal subjects
-
Ridge, S. A., Worwood, M., Oscier, D., Jacobs, A. &Padua, R. A. FMSmutations in myelodysplastic, leukemic, and normal subjects. Proc. Natl. Acad. Sci. U. S. A. 87, 1377-1380 (1990).
-
(1990)
Proc. Natl. Acad. Sci. U. S. A.
, vol.87
, pp. 1377-1380
-
-
Ridge, S.A.1
Worwood, M.2
Oscier, D.3
Jacobs, A.4
Padua, R.A.5
-
24
-
-
84864859511
-
European consensus document on mast cell tumours in dogs and cats
-
Blackwood, L. et al. European consensus document on mast cell tumours in dogs and cats. Vet. Comp. Oncol. 10, e1-e29 (2012).
-
(2012)
Vet. Comp. Oncol
, vol.10
, pp. e1-e29
-
-
Blackwood, L.1
-
25
-
-
84879562386
-
Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours
-
Amagai, Y. et al.Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours. J. Small Anim. Pract. 54, 377-380 (2013).
-
(2013)
J. Small Anim. Pract
, vol.54
, pp. 377-380
-
-
Amagai, Y.1
-
26
-
-
51649105768
-
Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors
-
Letard, S. et al. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Mol. Cancer. Res. 6, 1137-1145 (2008).
-
(2008)
Mol. Cancer. Res
, vol.6
, pp. 1137-1145
-
-
Letard, S.1
-
27
-
-
79957940523
-
Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit 1523A. T mutation via suppression of constitutive KIT activation
-
Yamada, O. et al. Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit 1523A. T mutation via suppression of constitutive KIT activation. Vet. Immunol. Immunopathol. 142, 101-106 (2011).
-
(2011)
Vet. Immunol. Immunopathol
, vol.142
, pp. 101-106
-
-
Yamada, O.1
-
28
-
-
0028181489
-
Mast cell and neutrophil expression of dog mast cell protease-3. A novel tryptase-related serine protease
-
Yezzi, M. J., Hsieh, I. E. & Caughey, G. H. Mast cell and neutrophil expression of dog mast cell protease-3. A novel tryptase-related serine protease. J. Immunol. 152, 3064-3072 (1994).
-
(1994)
J. Immunol
, vol.152
, pp. 3064-3072
-
-
Yezzi, M.J.1
Hsieh, I.E.2
Caughey, G.H.3
-
29
-
-
0034254249
-
Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
-
Heinrich, M. C. et al. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96, 925-932 (2000).
-
(2000)
Blood
, vol.96
, pp. 925-932
-
-
Heinrich, M.C.1
-
30
-
-
2942542387
-
Structural basis for the autoinhibition and STI-571 inhibition of c- Kit tyrosine kinase
-
Mol, C. D. et al. Structural basis for the autoinhibition and STI-571 inhibition of c- Kit tyrosine kinase. J. Biol. Chem. 279, 31655-31663 (2004).
-
(2004)
J. Biol. Chem
, vol.279
, pp. 31655-31663
-
-
Mol, C.D.1
-
31
-
-
80053343769
-
The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor
-
Ma, P. et al. The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood 118, 3459-3469 (2011).
-
(2011)
Blood
, vol.118
, pp. 3459-3469
-
-
Ma, P.1
-
32
-
-
84879585314
-
The phosphoinositide 3-kinase pathway is crucial for the growth of canine mast cell tumors
-
Amagai, Y. et al. The phosphoinositide 3-kinase pathway is crucial for the growth of canine mast cell tumors. J. Vet. Med. Sci. 75, 791-794 (2013).
-
(2013)
J. Vet. Med. Sci
, vol.75
, pp. 791-794
-
-
Amagai, Y.1
-
33
-
-
0023477326
-
Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67
-
Lalor, P. A., Mapp, P., Hall, P. & Revell, P. Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol. Int. 7, 183-186 (1987).
-
(1987)
Rheumatol. Int
, vol.7
, pp. 183-186
-
-
Lalor, P.A.1
Mapp, P.2
Hall, P.3
Revell, P.4
-
34
-
-
34447531743
-
Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor
-
Yuzawa, S. et al. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 130, 323-334 (2007).
-
(2007)
Cell
, vol.130
, pp. 323-334
-
-
Yuzawa, S.1
-
35
-
-
36749027045
-
Fams-ace: A combined method to select the best model after remodeling all server models
-
Terashi, G. et al. Fams-ace: A combined method to select the best model after remodeling all server models. Proteins 69, 98-107 (2007).
-
(2007)
Proteins
, vol.69
, pp. 98-107
-
-
Terashi, G.1
-
36
-
-
13844251975
-
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
-
Weisberg, E. et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer cell 7, 129-141 (2005).
-
(2005)
Cancer Cell
, vol.7
, pp. 129-141
-
-
Weisberg, E.1
-
37
-
-
0031766635
-
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
-
Livnah, O. et al. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat. Struct. Biol. 5, 993-1004 (1998).
-
(1998)
Nat. Struct. Biol
, vol.5
, pp. 993-1004
-
-
Livnah, O.1
-
38
-
-
0033548048
-
Erythropoietin receptor activation by a ligand-induced conformation change
-
Remy, I., Wilson, I. A. & Michnick, S. W. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283, 990-993 (1999).
-
(1999)
Science
, vol.283
, pp. 990-993
-
-
Remy, I.1
Wilson, I.A.2
Michnick, S.W.3
-
39
-
-
0030614530
-
Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation
-
Burke, C. L., Lemmon, M. A., Coren, B. A., Engelman, D. M. & Stern, D. F. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene 14, 687-696 (1997).
-
(1997)
Oncogene
, vol.14
, pp. 687-696
-
-
Burke, C.L.1
Lemmon, M.A.2
Coren, B.A.3
Engelman, D.M.4
Stern, D.F.5
-
40
-
-
0022979880
-
Synthesis of epidermal growth factor receptor in human A431 cells. Glycosylation-dependent acquisition of ligand binding activity occurs post-translationally in the endoplasmic reticulum
-
Slieker, L. J., Martensen, T. M. & Lane, M. D. Synthesis of epidermal growth factor receptor in human A431 cells. Glycosylation-dependent acquisition of ligand binding activity occurs post-translationally in the endoplasmic reticulum. J. Biol. Chem. 261, 15233-15241 (1986).
-
(1986)
J. Biol. Chem
, vol.261
, pp. 15233-15241
-
-
Slieker, L.J.1
Martensen, T.M.2
Lane, M.D.3
-
41
-
-
0034639255
-
Alternative glycosylation of the insulin receptor prevents oligomerization and acquisition of insulin-dependent tyrosine kinase activity
-
Hwang, J. B., Hernandez, J., Leduc, R. & Frost, S. C. Alternative glycosylation of the insulin receptor prevents oligomerization and acquisition of insulin-dependent tyrosine kinase activity. Biochim. Biophys. Acta. 1499, 74-84 (2000).
-
(2000)
Biochim. Biophys. Acta
, vol.1499
, pp. 74-84
-
-
Hwang, J.B.1
Hernandez, J.2
Leduc, R.3
Frost, S.C.4
-
42
-
-
17644388474
-
Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases
-
Schmidt-Arras, D. E. et al. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol. Cell. Biol. 25, 3690-3703 (2005).
-
(2005)
Mol. Cell. Biol
, vol.25
, pp. 3690-3703
-
-
Schmidt-Arras, D.E.1
-
43
-
-
0029671080
-
FGFR2 exon IIIa and IIIcmutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: Evidence for missense changes, insertions, and a deletion due to alternative RNA splicing
-
Meyers, G.A. et al. FGFR2 exon IIIa and IIIcmutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am. J. Hum. Genet. 58, 491-498 (1996).
-
(1996)
Am. J. Hum. Genet
, vol.58
, pp. 491-498
-
-
Meyers, G.A.1
-
44
-
-
0029816813
-
Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras
-
Galvin, B. D., Hart, K. C., Meyer, A. N., Webster, M. K. & Donoghue, D. J. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc. Natl. Acad. Sci. U. S. A. 93, 7894-7899 (1996).
-
(1996)
Proc. Natl. Acad. Sci. U. S. A.
, vol.93
, pp. 7894-7899
-
-
Galvin, B.D.1
Hart, K.C.2
Meyer, A.N.3
Webster, M.K.4
Donoghue, D.J.5
-
45
-
-
0032515975
-
Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain
-
Robertson, S. C. et al. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc. Natl. Acad. Sci. U. S. A. 95, 4567-4572 (1998).
-
(1998)
Proc. Natl. Acad. Sci. U. S. A.
, vol.95
, pp. 4567-4572
-
-
Robertson, S.C.1
-
46
-
-
0030801361
-
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
-
Arteaga, C. L., Ramsey, T. T., Shawver, L. K. & Guyer, C. A. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. J. Biol. Chem. 272, 23247-23254 (1997).
-
(1997)
J. Biol. Chem
, vol.272
, pp. 23247-23254
-
-
Arteaga, C.L.1
Ramsey, T.T.2
Shawver, L.K.3
Guyer, C.A.4
-
47
-
-
78649720878
-
Kinase-mediated quasi-dimers of EGFR
-
Bublil, E. M. et al. Kinase-mediated quasi-dimers of EGFR. FASEB J. 24, 4744-4755 (2010).
-
(2010)
FASEB J
, vol.24
, pp. 4744-4755
-
-
Bublil, E.M.1
-
48
-
-
34047273010
-
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806
-
Gan, H. K. et al. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. J. Biol. Chem. 282, 2840-2850 (2007).
-
(2007)
J. Biol. Chem
, vol.282
, pp. 2840-2850
-
-
Gan, H.K.1
-
49
-
-
54349093009
-
Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells
-
Ohmori, K. et al. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells. Vet. Immunol. Immunopathol. 126, 43-53 (2008).
-
(2008)
Vet. Immunol. Immunopathol
, vol.126
, pp. 43-53
-
-
Ohmori, K.1
-
50
-
-
0033214269
-
Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation
-
Tanaka, A., Arai, K., Kitamura, Y. & Matsuda, H. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood 94, 2390-2395 (1999).
-
(1999)
Blood
, vol.94
, pp. 2390-2395
-
-
Tanaka, A.1
Arai, K.2
Kitamura, Y.3
Matsuda, H.4
-
51
-
-
15244341289
-
A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors
-
Tanaka, A. et al. A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood 105, 2324-2331 (2005).
-
(2005)
Blood
, vol.105
, pp. 2324-2331
-
-
Tanaka, A.1
-
52
-
-
80054116296
-
Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease
-
Okamoto, N. et al. Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease. Cardiovasc. Res. 92, 209-217 (2011).
-
(2011)
Cardiovasc. Res
, vol.92
, pp. 209-217
-
-
Okamoto, N.1
|